Percy Lee

TL;DR: This trial aimed to assess disease control and pulmonary toxicity in patients who previously received radiotherapy for non-small-cell lung cancer (NSCLC) before receiving pembrolizumab to determine whether previous radiotherapy affected progression-free survival, overall survival, and pulmonaryoxicity in the intention-to-treat population.

TL;DR: It was concluded that NRP1 expression results in enlarged tumors associated with substantially enhanced tumor angiogenesis and progression and was induced in vivo and AT2.1 cell tumor size was increased 2.5‐ to 7‐fold in a 3–4 wk period compared to controls.

TL;DR: The result was a potent inhibition of blood cell circulation via both intersegmental and axial vessels demonstrating that VEGF and NRP1 act synergistically to promote a functional circulatory system.

TL;DR: Outcomes of inoperable pancreatic cancer patients treated using MRgRT with and without dose escalation are evaluated.

TL;DR: Metabolic tumor volume is an adverse prognostic factor for disease recurrence and death in HNC and is a potentially valuable tool for risk stratification and guiding treatment in future studies.